# TOPIRAMATE
> **ANDA210278** · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2021-02-01
## Drug
- **FDA Application Number:** ANDA210278
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TOPIRAMATE
- **Generic name:** TOPIRAMATE
- **Active ingredients:** TOPIRAMATE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GLENMARK PHARMS LTD
- **Manufacturer:** NorthStar RxLLC
- **First approval:** 2021-02-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210278)
---
*AI Analytics · CC0 1.0*